Consumer knowledge is increasing,evidence is building, legislation is changing, perspectives are shifting, clinical benefits are expanding, and physicians are aligning. There’s a movement that’s impossible to ignore.

The human endocannabinoid system (ECS) is a unique system active in multiple dimensions with a very wide scope of influence due to an abundance of cannabinoid receptors (e.g., CB1 and CB2 cannabinoid receptors, etc.) located everywhere from immune cells to neurons.

Powered by endogenous ligands (endocannabinoids) and metabolizing enzymes, the ECS plays an important role in different physiological and pathological processes, including fertility, pain, energy regulation, neurotransmission, glial activation, oxidative stress, protein homeostasis, emotional and non-emotional behaviors, mood, and memory.

As the universal regulator, the ECS plays a unique and critical role in maintaining balance throughout all systems of the human body, and works to maintain, activate, repair, and restore endogenous health processes.

The ECS has the power to change the way we approach medicine and wellbeing, allowing us to change our focus from invasive pharmacological interventions to repairing the body’s failing ability to maintain homeostasis in multiple disease states.